Oxalatoplatin
Categoria
Oxalatoplatin Marchi, Oxalatoplatin Analoghi
Oxalatoplatin Marchi miscela
Oxalatoplatin Formula chimica
Oxalatoplatin RX link
Oxalatoplatin FDA foglio
Oxalatoplatin DMS (foglio di materiale di sicurezza)
Oxalatoplatin Sintesi di riferimento
Oxalatoplatin Peso molecolare
Oxalatoplatin Temperatura di fusione
Oxalatoplatin H2O Solubilita
Oxalatoplatin Stato
Oxalatoplatin LogP
Oxalatoplatin Forme di dosaggio
Oxalatoplatin Indicazione
Oxalatoplatin Farmacologia
Oxalatoplatin Assorbimento
Oxalatoplatin Tossicita
Oxalatoplatin Informazioni paziente
Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.
Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.
Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.
